All In Biotech

Drug Trial Radar · NCT07292025

Phase 1 Trial of JTM201 in Subjects With Post-stroke Upper Limb Spasticity

A Randomized, Double-blind, Active-controlled, Multicenter, Phase 1 Trial to Investigate the Safety and Efficacy of JTM201 in Subjects With Post-stroke Upper Limb Spasticity

Last checked: Nov 19, 2026Latest source record: Dec 18, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

30

Actual

Start

Jun 29, 2023

Primary completion

Apr 22, 2024

Study completion Sep 4, 2024

Sponsor

Lead sponsor
Jetema Co., Ltd.Industry
Sponsor type
Industry
First posted
Dec 18, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 19 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Phase 1 trial to evaluate the safety and efficacy of JTM201 compared with 'Botox® Inj.' in subjects with post-stroke upper limb spasticity

Conditions

  • Upper Limb Spasticity Post-Stroke

Interventions

  • JTM201 in normal salineDrug

    Max 360 U of Test drug IM

  • BOTOX 100U in normal salineDrug

    Max 360 U of BOTOX IM

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline in Modified Ashworth Scale score of Wrist FlexorTime frame: Week 4, Week 8, Week 12
  2. Change from baseline in Modified Ashworth Scale score of Elbow Flexor, Finger FlexorTime frame: Week 4, Week 8, Week 12
  3. Proportion of subjects with at least 1-point improvement from baseline in the Modified Ashworth Scale score for the Wrist Flexor, Elbow Flexor, Finger FlexorTime frame: Week 4, Week 8, Week 12
  4. Changes from baseline in Disability Assessment Scale scoreTime frame: Week 4, Week 8, Week 12
  5. Global Assessment Scale evaluated by investigatorTime frame: Week 4, Week 8, Week 12
  6. Global Assessment Scale evaluated by patientsTime frame: Visit 3, 4, 5
  7. Change from baseline in Caregiver Burden Scale completed by caregiverTime frame: Week 4, Week 8, Week 12

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Seoul Boramae Hospital

    Seoul, South Korea

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.